FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280623107> ?p ?o ?g. }

• W4280623107 endingPage "2814" @default.
• W4280623107 startingPage "2814" @default.
• W4280623107 abstract "Osteoarthritis (OA) is no longer considered a purely degenerative disease. OA is defined as a disease of the entire joint, in which inflammation occurs in various joint tissues. The overall aim of this study was to analyze the presence and polarization of CD8+ T cell subsets in OA knee joints, in relation to the OA stage and compartment (synovial fluid (SF), synovial membrane (SM,) peripheral blood (PB)). A quantitative flow analysis of CD8+ T cell subsets to compare the SF, SM, PB, was performed in patients with different stages of OA (early, unicondylar and bicondylar OA). Samples of the SF, SM and PB were harvested from a total of 55 patients at the time of surgery. Early OA was confirmed by independent surgeons intraoperatively. Uni- and bicondylar OA was confirmed and graded by two plane radiographs. Samples were analyzed by flow cytometry for surface markers, and cytokines by intracellular staining (ICS). CD8+ T cells were shown to be differentiated into pro-inflammatory IFN-γ producing Tc1 and IL-17A producing Tc17, as well as anti-inflammatory IL-4 producing Tc2. All CD8+ T cell subsets (Tc1, Tc17, and Tc2) were detected in both the SM and SF. The percentage of CD8+ T cell subsets of the total CD8+ T cell population was dependent on the OA stage and compartment. Compared with the peripheral blood (PB), the proportion of CD8+IFN-γ+ Tc1 and CD8+IL-17A+ Tc17 was significantly increased in OA SF. This was confirmed in our data for both early OA and end-stage OA. In the SM samples of end-stage OA patients, the proportion of CD8+IL-17A+ Tc17 was significantly increased compared to the PB. Comparing SF and SM samples of end-stage OA patients, the proportion of CD8+IFN-γ+ Tc1 was significantly increased in SF, whereas there were no differences concerning CD8+IL-4+ Tc2 and CD8+IL-17A+ Tc17. End-stage OA samples showed a significant increase of CD8+IL-4+ Tc2 in the SM for both unicondylar and bicondylar OA compared to early OA. CD8+ T cells infiltrating the SM and SF in OA knees are differentiated into IFN-γ-, IL-17A-, and IL-4-producing CD8+ T cell subsets (Tc1, Tc17, Tc2). This differentiation depends on the OA stage and OA compartment. Further investigation of CD8+ T cell subsets and their interaction with other inflammatory cells such as CD4+ T cells and macrophages may help to identify novel therapeutic anti-inflammatory strategies for containing OA progression." @default.
• W4280623107 created "2022-05-22" @default.
• W4280623107 creator A5023285181 @default.
• W4280623107 creator A5028792104 @default.
• W4280623107 creator A5033557216 @default.
• W4280623107 creator A5035943230 @default.
• W4280623107 creator A5074133881 @default.
• W4280623107 creator A5076343078 @default.
• W4280623107 creator A5080165844 @default.
• W4280623107 creator A5082400851 @default.
• W4280623107 date "2022-05-17" @default.
• W4280623107 modified "2023-10-14" @default.
• W4280623107 title "CD8+ T Cells in OA Knee Joints Are Differentiated into Subsets Depending on OA Stage and Compartment" @default.
• W4280623107 cites W1955548028 @default.
• W4280623107 cites W1965398132 @default.
• W4280623107 cites W1967469609 @default.
• W4280623107 cites W1973923090 @default.
• W4280623107 cites W1980212706 @default.
• W4280623107 cites W1982483937 @default.
• W4280623107 cites W1983085370 @default.
• W4280623107 cites W1985037320 @default.
• W4280623107 cites W2013352191 @default.
• W4280623107 cites W2017348165 @default.
• W4280623107 cites W2046933619 @default.
• W4280623107 cites W2054472394 @default.
• W4280623107 cites W2057320783 @default.
• W4280623107 cites W2075791473 @default.
• W4280623107 cites W2095233090 @default.
• W4280623107 cites W2097993952 @default.
• W4280623107 cites W2114128492 @default.
• W4280623107 cites W2138493223 @default.
• W4280623107 cites W2141363952 @default.
• W4280623107 cites W2147174959 @default.
• W4280623107 cites W2153192975 @default.
• W4280623107 cites W2161106513 @default.
• W4280623107 cites W2164993228 @default.
• W4280623107 cites W2398042202 @default.
• W4280623107 cites W244647256 @default.
• W4280623107 cites W2565829915 @default.
• W4280623107 cites W2744099886 @default.
• W4280623107 cites W2802780839 @default.
• W4280623107 cites W2898528751 @default.
• W4280623107 cites W2941520070 @default.
• W4280623107 cites W2981318410 @default.
• W4280623107 cites W3021945564 @default.
• W4280623107 cites W3039693333 @default.
• W4280623107 cites W3123574977 @default.
• W4280623107 doi "https://doi.org/10.3390/jcm11102814" @default.
• W4280623107 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35628940" @default.
• W4280623107 hasPublicationYear "2022" @default.
• W4280623107 type Work @default.
• W4280623107 citedByCount "3" @default.
• W4280623107 countsByYear W42806231072022 @default.
• W4280623107 countsByYear W42806231072023 @default.
• W4280623107 crossrefType "journal-article" @default.
• W4280623107 hasAuthorship W4280623107A5023285181 @default.
• W4280623107 hasAuthorship W4280623107A5028792104 @default.
• W4280623107 hasAuthorship W4280623107A5033557216 @default.
• W4280623107 hasAuthorship W4280623107A5035943230 @default.
• W4280623107 hasAuthorship W4280623107A5074133881 @default.
• W4280623107 hasAuthorship W4280623107A5076343078 @default.
• W4280623107 hasAuthorship W4280623107A5080165844 @default.
• W4280623107 hasAuthorship W4280623107A5082400851 @default.
• W4280623107 hasBestOaLocation W42806231071 @default.
• W4280623107 hasConcept C111368507 @default.
• W4280623107 hasConcept C126322002 @default.
• W4280623107 hasConcept C127313418 @default.
• W4280623107 hasConcept C142724271 @default.
• W4280623107 hasConcept C146357865 @default.
• W4280623107 hasConcept C151730666 @default.
• W4280623107 hasConcept C167672396 @default.
• W4280623107 hasConcept C203014093 @default.
• W4280623107 hasConcept C203635412 @default.
• W4280623107 hasConcept C204787440 @default.
• W4280623107 hasConcept C2776090121 @default.
• W4280623107 hasConcept C2776164576 @default.
• W4280623107 hasConcept C2776268809 @default.
• W4280623107 hasConcept C2908647359 @default.
• W4280623107 hasConcept C553184892 @default.
• W4280623107 hasConcept C71924100 @default.
• W4280623107 hasConcept C86803240 @default.
• W4280623107 hasConcept C8891405 @default.
• W4280623107 hasConcept C99454951 @default.
• W4280623107 hasConceptScore W4280623107C111368507 @default.
• W4280623107 hasConceptScore W4280623107C126322002 @default.
• W4280623107 hasConceptScore W4280623107C127313418 @default.
• W4280623107 hasConceptScore W4280623107C142724271 @default.
• W4280623107 hasConceptScore W4280623107C146357865 @default.
• W4280623107 hasConceptScore W4280623107C151730666 @default.
• W4280623107 hasConceptScore W4280623107C167672396 @default.
• W4280623107 hasConceptScore W4280623107C203014093 @default.
• W4280623107 hasConceptScore W4280623107C203635412 @default.
• W4280623107 hasConceptScore W4280623107C204787440 @default.
• W4280623107 hasConceptScore W4280623107C2776090121 @default.
• W4280623107 hasConceptScore W4280623107C2776164576 @default.
• W4280623107 hasConceptScore W4280623107C2776268809 @default.
• W4280623107 hasConceptScore W4280623107C2908647359 @default.
• W4280623107 hasConceptScore W4280623107C553184892 @default.

• next